European Medicines Agency approves Paxlovid, Pfizer's anti-Covid pill
Steph Deschamps / January 28, 2022
The European Medicines Agency (EMA) said Thursday it has approved Pfizer's anti-Covid pill, which becomes the first orally taken antiviral drug approved in the European Union.
The EMA recommended authorizing Paxlovid for the treatment of Covid-19 in adults who do not require supplemental oxygen and are at increased risk of the disease becoming severe, the European regulator said in a statement.
With the approval of Paxlovid this week, 6 anti-Covid drugs have been approved as part of the EU therapeutic strategy, European Commissioner for Health and Food Safety Stella Kyriakides welcomed in a statement.
The United States, Canada and Israel are among a handful of countries that have already given the green light to Pfizer's treatment.
Related Posts
The new variant of the coronavirus classified of concern by the WHO and named Omicron
Sylvie Claire / November 27, 2021
The new variant is now called Omicron. Experts mandated by the World Health Organ...
Read More
Coronavirus: Russian Sputnik V vaccine developers claim longer efficacy
Sylvie Claire / November 25, 2021
The developers of Sputnik V said Wednesday that the Russian vaccine was more effe...
Read More
First in Europe: Austria makes vaccination against Covid-19 mandatory
Sylvie Claire / November 20, 2021
Austria will confine its entire population as of Monday and has decided to make...
Read More